INTECH Investment Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-675
Closed -$17.7K – 2175
2026
Q1
$17.7K Sell
675
-395
-37% -$49.7K ﹤0.01% 2070
2025
Q4
$265K Sell
1,070
-191
-15% -$43.6K ﹤0.01% 1821
2025
Q3
$265K Buy
1,261
+32
+3% +$5.64K ﹤0.01% 1902
2025
Q2
$121K Buy
+1,229
New +$107K ﹤0.01% 2245

Other funds holding GOSS

INTECH Investment Management's GOSS Position: Q2 2026 in Review

INTECH Investment Management sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 675 shares — an estimated $17.7K sold.

INTECH Investment Management first reported a position in GOSS in Q2 2025 and held it in 4 quarters. The position peaked at $265K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • INTECH Investment Management reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • INTECH Investment Management sold 675 Gossamer Bio shares in Q2 2026, an estimated $17.7K.
  • INTECH Investment Management first reported a position in Gossamer Bio in Q2 2025 and held it in 4 quarters.
  • INTECH Investment Management's Gossamer Bio position peaked at $265K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.